会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明申请
    • Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites
    • 具有对多巴胺-D2受体和5-羟色胺再摄取位点的亲和力的组合的四氢吡啶-4-基吲哚
    • US20060122206A1
    • 2006-06-08
    • US11294657
    • 2005-12-06
    • Roelof HesPieter SmidCornelis KruseMartinus Tulp
    • Roelof HesPieter SmidCornelis KruseMartinus Tulp
    • A61K31/513C07D403/14
    • C07D401/14
    • The present invention relates to a group of novel tetrahydropyridin-4-yl indoles with a dual mode of action: serotonin reuptake inhibition and affinity for dopamine-D2 receptors, to methods for the preparation of these compounds and to novel intermediates useful for the synthesis of said tetrahydropyridin-4-yl indoles. The invention also relates to the use of a compound disclosed herein for the manufacture of a medicament giving a beneficial effect. The invention relates to novel tetrahydropyridin-4-yl indoles of the formula. and tautomers, stereoisomers, prodrugs, N-oxides, pharmacologically acceptable salts, hydrates and solvates thereof, wherein: R1 is hydrogen, halogen, alkyl(C1-3) or alkoxy(C1-3), CN or CF3, R2 is hydrogen or alkyl(C1-3), R3 is hydrogen or alkyl(C1-3), Z is hydrogen or alkyl(C1-3), alkoxy(C1-3) or alkylthio(C1-3), A is hydrogen or alkyl(C1-3), or A and Z together form a saturated or (partly) unsaturated 5- or 6-membered ring which may be substituted with halogen, alkyl (C1-3) or phenyl, in which ring Z represents carbon, sulfur of nitrogen.
    • 本发明涉及一组具有双重作用方式的新的四氢吡啶-4-基吲哚:5-羟色胺再摄取抑制和对多巴胺-D 2受体的亲和性,制备这些化合物的方法和 涉及可用于合成所述四氢吡啶-4-基吲哚的新型中间体。 本发明还涉及本文公开的化合物在制备产生有益效果的药物中的用途。 本发明涉及下式的新的四氢吡啶-4-基吲哚。 和其互变异构体,立体异构体,前药,N-氧化物,其药理学上可接受的盐,水合物和溶剂化物,其中:R 1是氢,卤素,烷基(C 1-3 - 或烷氧基(C 1-3 - ),CN或CF 3 R 2,R 2是氢或烷基(C 1-3 - R 3是氢或烷基(C 1-3),Z是氢或烷基(C 1-3) ,烷氧基(C 1-3-3)或烷硫基(C 1-3-3),A是氢或烷基(C 1-3-3), 或A和Z一起形成饱和或(部分)不饱和的5或6元环,其可被卤素,烷基(C 1-3-3)或苯基取代,其中环Z表示碳 ,硫氮。
    • 8. 发明申请
    • TETRAHYDROPYRIDIN-4-YL INDOLES WITH A COMBINATION OF AFFINITY FOR DOPAMINE-D2 RECEPTORS AND SEROTONIN REUPTAKE SITES
    • 具有多巴胺D2受体和丝氨酸蛋白酶重复位点的亲和力组合的四氢吡啶并[4-YL]吲哚
    • US20070066634A2
    • 2007-03-22
    • US11294657
    • 2005-12-06
    • Roelof van HesPieter SmidCornelis KruseMartinus Tulp
    • Roelof van HesPieter SmidCornelis KruseMartinus Tulp
    • A61K31/513C07D403/14
    • C07D401/14
    • The present invention relates to a group of novel tetrahydropyridin-4-yl indoles with a dual mode of action: serotonin reuptake inhibition and affinity for dopamine-D2 receptors, to methods for the preparation of these compounds and to novel intermediates useful for the synthesis of said tetrahydropyridin-4-yl indoles. The invention also relates to the use of a compound disclosed herein for the manufacture of a medicament giving a beneficial effect. The invention relates to novel tetrahydropyridin-4-yl indoles of the formula. and tautomers, stereoisomers, prodrugs, N-oxides, pharmacologically acceptable salts, hydrates and solvates thereof, wherein: R1 is hydrogen, halogen, alkyl(C1-3) or alkoxy(C1-3), CN or CF3, R2 is hydrogen or alkyl(C1-3), R3 is hydrogen or alkyl(C1-3), Z is hydrogen or alkyl(C1-3), alkoxy(C1-3) or alkylthio(C1-3), A is hydrogen or alkyl(C1-3), or A and Z together form a saturated or (partly) unsaturated 5- or 6- membered ring which may be substituted with halogen, alkyl (C1-3) or phenyl, in which ring Z represents carbon, sulfur of nitrogen.
    • 本发明涉及一组具有双重作用方式的新的四氢吡啶-4-基吲哚:5-羟色胺再摄取抑制和对多巴胺-D 2受体的亲和性,制备这些化合物的方法和 涉及可用于合成所述四氢吡啶-4-基吲哚的新型中间体。 本发明还涉及本文公开的化合物在制备产生有益效果的药物中的用途。 本发明涉及下式的新的四氢吡啶-4-基吲哚。 和其互变异构体,立体异构体,前药,N-氧化物,其药理学上可接受的盐,水合物和溶剂化物,其中:R 1是氢,卤素,烷基(C 1-3 - 或烷氧基(C 1-3 - ),CN或CF 3 R 2,R 2是氢或烷基(C 1-3 - R 3是氢或烷基(C 1-3),Z是氢或烷基(C 1-3) ,烷氧基(C 1-3-3)或烷硫基(C 1-3-3),A是氢或烷基(C 1-3-3), 或A和Z一起形成饱和或(部分)不饱和的5-或6-元环,其可以被卤素,烷基(C 1-3-3)或苯基取代,其中环Z表示碳 ,硫氮。
    • 10. 发明申请
    • FUSED HETEROCYCLIC DERIVATIVES AS S1P MODULATORS
    • US20130203737A1
    • 2013-08-08
    • US13808908
    • 2011-07-08
    • Pieter SmidWouter I. Iwema BakkerHein K.A.C. CoolenLeonardus A.J.M. SliedregtMaria J.P. van DongenJacobus A.J. den Hartog
    • Pieter SmidWouter I. Iwema BakkerHein K.A.C. CoolenLeonardus A.J.M. SliedregtMaria J.P. van DongenJacobus A.J. den Hartog
    • C07D513/04C07D495/04C07D487/04C07D471/04C07D491/048C07D498/04
    • C07D491/048C07D471/04C07D487/04C07D491/04C07D495/04C07D498/04C07D513/04
    • The present invention relates to a fused heterocyclic derivative of the formula (I) wherein R1 is selected from cyano, (2-4C)alkenyl, (2-4C)alkynyl, (1-4C)alkyl, each optionally substituted with CN or one or more fluoro atoms, (3-6C)cycloalkyl, (4-6C)cycloalkenyl or a (8-10C)bicyclic group, each optionally substituted with halogen or (1-4C)alkyl optionally substituted with one or more fluoro atoms, phenyl, biphenyl, naphthyl, each optionally substituted with one or more substituents independently selected from halogen, cyano, (1-4C)alkyl optionally substituted with one or more fluoro atoms, (1-4C)alkoxy optionally substituted with one or more fluoro atoms, amino, dimethylamino, and (3-6C)cycloalkyl optionally substituted with phenyl which may be substituted with (1-4C)alkyl or halogen, and phenyl substituted with phenoxy, benzyl, benzyloxy, phenylethyl or monocyclic heterocycle, each optionally substituted with (1-4C)alkyl, Z is a linking group —W—(Cn-alkylene)-T- wherein W is attached to R1 and selected from a bond, —O—, —CO—, —S—, —SO—, —SO2—, —NH—, —CH═CH—, —C(CF3)═CH—, —C≡C—, —CH2—O—, —O—CO—, —CO—O—, —CO—NH—, —NH—CO— and trans-cyclopropylene; n is an integer from 0 to 10; and T is attached to the phenylene/pyridyl moiety and selected from a bond, —O—, —S—, —SO—, —SO2—, —NH—, —CO—, —C═C—, —C≡C—, and trans-cyclopropylene; R2 is H or one or more substituents independently selected from cyano, halogen, (1-4C)alkyl optionally substituted with one or more halogen atoms, or (1-4C)alkoxy optionally substituted with one or more halogen atoms; ring structure A may contain one nitrogen atom; X is selected from C or N; if X is C, R3 is selected from H and (1-4C)alkyl, otherwise R3 is not present; Y is selected from NH, O and S; structure Q is a 5-, 6- or 7-membered cyclic amine; and R4 is (1-4C)alkylene-R5 wherein one or more carbon atoms in the alkylene group may independently be substituted with one or more halogen atoms or with (CH2)2 to form a cyclopropyl moiety, or R4 is (3-6C)cycloalkylene-R5, —CH2-(3-6C)cycloalkylene-R5, (3-6C)cycloalkylene-CH2-R5 or —CO—CH2-R5, wherein R5 is —OH, —PO3H2, —OPO3H2, —COOH, —COO(1-4C)alkyl or tetrazol-5-yl; or a pharmaceutically acceptable salt, a solvate or hydrate thereof or one or more N-oxides thereof. The compounds of the invention have affinity to S1P receptors and may be used in the treatment, alleviation or prevention of diseases and conditions in which (any) S1P receptor(s) is (are) involved or in which modulation of the endogenous S1P signaling system via any S1P receptor is involved.